COMP <GO>
MTD vs MRK // RETURN ON INVESTED CAPITAL (ROIC)
Mettler-Toledo International Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: MTD 6
— MRK 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MTD
LAST: $1,674.81 (-2.55%) • MKT CAP: $34.44B
roic
30.40%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
roic
20.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTD VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTD | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.40% | 74.80% | -15.40 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 30.40% | 20.70% | +9.70 | MTD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 31.7x | 15.3x | +16.40 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 2.46% | 3.42% | -0.96 | MRK | /fcf-yield <GO> |
| Operating Margin | 26.30% | 34.30% | -8.00 | MRK | /operating-margins <GO> |
| Net Profit Margin | 21.60% | 28.10% | -6.50 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 4.00% | 1.30% | +2.70 | MTD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.09 | 5.19 | +5.90 | MTD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | MTD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.60% | -0.10 | MTD | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 56.9 | +8.57 | MTD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.92 | -0.05 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.8x | 18.4x | +18.40 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $34.44B | $361.02B | -$326.59B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTD REV | MRK REV | MTD GROSS % | MRK GROSS % | MTD FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.03B | $65.01B | 59.4% | 74.8% | $848.6M | $12.36B |
| FY 2024 | $3.87B | $64.17B | 60.1% | 76.3% | $864.4M | $18.10B |
| FY 2023 | $3.79B | $60.12B | 44.0% | 44.0% | $795.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTD // BETA 0.87
MRK // BETA 0.92